바이오 살균제 시장 예측(2026-2032년)

The Biofungicides Market is projected to grow by USD 8.33 billion at a CAGR of 13.33% by 2032.

Biofungicides Executive Summary

Biofungicides are biological crop protection solutions derived from microorganisms, plant extracts, and other naturally occurring materials that suppress fungal and oomycete diseases through antagonism, competition, antibiosis, induced resistance, mycoparasitism, and microbiome modulation. Their relevance is rising as growers seek residue-compatible, resistance-management-oriented, and sustainability-aligned tools for controlling diseases such as powdery mildew, downy mildew, Botrytis, Fusarium, Rhizoctonia, Sclerotinia, Pythium, and Phytophthora across fruits, vegetables, cereals, oilseeds, pulses, turf, ornamentals, and protected cultivation systems. Demand is reinforced by stricter pesticide residue standards, export market requirements, soil health priorities, and the need to maintain effective disease control amid increasing resistance pressure from repeated use of single-site synthetic fungicides. Biofungicides are increasingly positioned within integrated pest management programs, where they complement chemical fungicides, cultural practices, resistant varieties, sanitation, irrigation management, and digital crop monitoring. Key product categories include microbial biofungicides based on Bacillus, Trichoderma, Pseudomonas, Streptomyces, Ampelomyces, and yeasts; biochemical products using plant-derived or mineral-origin active ingredients; and seed treatment, foliar, soil-applied, and post-harvest formulations designed for specific crop-disease windows. The sector's competitive strength depends on consistent field efficacy, formulation stability, shelf life, compatibility with tank mixes, grower education, regulatory acceptance, and reliable manufacturing of living organisms at commercial quality standards.

Transformative Shifts in the Biofungicides Landscape

The biofungicides landscape is shifting from niche organic inputs toward mainstream biological crop protection integrated with conventional disease management. Regulatory policy is a central driver: many jurisdictions are tightening scrutiny of chemical pesticide residues, endocrine and environmental risk, pollinator impacts, and soil and water contamination, creating stronger incentives for lower-risk biological alternatives. At the same time, organic agriculture, regenerative agriculture, and sustainability-linked procurement are increasing the visibility of biological fungicide tools, especially in high-value horticulture and export-oriented crops where residue compliance is commercially critical. Scientific progress is also transforming the sector. Advances in microbial screening, genomics, fermentation, metabolomics, and formulation science are improving strain selection, mode-of-action understanding, and product durability under variable field conditions. Growers are adopting biofungicides not only for disease suppression but also for broader plant health outcomes, including root vigor, stress tolerance, and rhizosphere balance. Distribution channels are evolving as agronomists, cooperatives, retailers, and digital advisory platforms provide more crop-stage-specific guidance. However, adoption remains shaped by practical constraints: biological products are often more sensitive to timing, temperature, humidity, ultraviolet exposure, storage conditions, water quality, and application technique than conventional fungicides. The most successful strategies are therefore moving toward integrated protocols, localized efficacy validation, and education that helps growers understand when biological fungicides prevent disease most effectively rather than treating advanced infections after pressure is already high.

Cumulative Impact of Artificial Intelligence on Biofungicides

Artificial intelligence is increasing the precision, reliability, and scalability of biofungicide discovery, development, manufacturing, and field deployment. In discovery, machine learning supports the screening of microbial libraries by identifying candidate strains with antifungal metabolites, competitive colonization traits, stress tolerance, and compatibility with specific crop systems. AI-enabled bioinformatics can connect genomic markers with functional traits, helping researchers prioritize Bacillus, Trichoderma, Pseudomonas, Streptomyces, yeast, and other beneficial organisms for further validation. In formulation development, predictive analytics can evaluate how carriers, adjuvants, drying methods, packaging, and storage conditions influence viability, shelf life, and application performance. In manufacturing, AI-driven process control can optimize fermentation parameters such as pH, temperature, dissolved oxygen, substrate use, and contamination risk, supporting batch consistency for live microbial products. At the farm level, artificial intelligence strengthens integrated disease management by combining weather data, canopy imaging, spore-trap data, crop phenology, soil conditions, irrigation patterns, and historical disease occurrence to recommend preventive application windows. This is especially important for biofungicides because biological efficacy often depends on early placement before pathogen outbreaks become severe. AI can also support resistance management by guiding rotation programs that combine biological and chemical modes of action while reducing unnecessary spray events. The cumulative impact is a more evidence-based biological fungicide sector where product selection, application timing, and performance monitoring become increasingly data-driven.

Key Regional Insights for Biofungicides

Asia-Pacific is becoming a major center for biofungicide adoption due to its diverse cropping systems, large base of smallholder and commercial farms, expanding protected cultivation, and policy attention to soil health and pesticide residue reduction. The region's horticulture, rice, tea, cotton, pulses, and vegetable systems create demand for biological disease management, while tropical and subtropical climates intensify fungal disease pressure and require locally validated application protocols. Europe remains strongly shaped by stringent pesticide regulation, organic farming policy, biodiversity objectives, and residue-sensitive food supply chains, making biofungicides strategically important in fruit, vegetable, vineyard, cereal, and protected crop disease programs. North America is characterized by strong integrated pest management adoption, mature agricultural extension networks, and growing use of biological fungicides in specialty crops, greenhouse production, turf, seed treatment, and broadacre systems where resistance management and residue control are priorities. Latin America is influenced by high disease pressure in soybean, corn, coffee, sugarcane, fruits, and vegetables, and by increasing interest in biological inputs that support intensive production under humid and variable climates. Africa presents growing relevance for biofungicides in smallholder and commercial agriculture, particularly where post-harvest losses, soilborne diseases, limited access to conventional chemistry, and the need for safer crop protection tools intersect with expanding agricultural modernization and regional food security priorities. The Middle East faces water scarcity, saline soils, and rapid growth in controlled-environment agriculture, creating opportunities for biological fungicides compatible with greenhouse vegetables, date palms, and high-value horticulture.

Key Group Insights for Biofungicides

NATO countries, while not an agricultural trade bloc, include many advanced farming economies where biofungicide relevance is linked to resilient food systems, input security, reduced environmental exposure, and the modernization of sustainable crop protection practices. G7 countries generally show high emphasis on food safety, science-based regulation, precision agriculture, and integrated pest management, supporting adoption where efficacy data, product quality, and agronomic service are strong. The European Union provides one of the most regulation-driven environments for biological crop protection, with pesticide risk reduction policies, organic production targets, biodiversity objectives, and residue standards reinforcing interest in microbial and biochemical fungicide alternatives, though regulatory approval timelines and country-level implementation complexity remain important considerations. BRICS economies combine large agricultural land bases, diverse climates, strong domestic food demand, and increasing biological input capabilities; biofungicides in these markets are tied to disease management in cereals, oilseeds, pulses, horticulture, and export crops, with localized manufacturing and strain adaptation playing a key role. ASEAN countries are increasingly relevant for biofungicides because humid tropical production environments intensify disease pressure in rice, fruits, vegetables, oil palm, rubber, and plantation crops, while export markets encourage residue-conscious crop protection practices. Adoption is strengthened when products are adapted to high-temperature storage, monsoon-season application challenges, and smallholder distribution systems. The GCC is shaped by arid agriculture, greenhouse expansion, food security strategies, and water-efficient production, making biofungicides particularly relevant for protected vegetables, ornamentals, and date palm systems where biological inputs can be integrated with fertigation, substrate production, and controlled-environment monitoring.

Key Country Insights for Biofungicides

The United States is a leading adoption environment for biofungicides due to extensive specialty crop production, greenhouse systems, seed treatment use, organic agriculture, and integrated pest management programs focused on resistance management and residue compliance. China is advancing biological agriculture through policy interest in pesticide reduction, large-scale horticulture, greenhouse expansion, rice, wheat, corn, and vegetable production, with growing domestic biological input capabilities. Germany emphasizes science-based crop protection, cereals, potatoes, vineyards, and strict environmental expectations, while Japan's precision-oriented agriculture, protected horticulture, rice systems, and food safety expectations support targeted biological fungicide use. India's use potential is linked to smallholder agriculture, vegetables, fruits, rice, cotton, pulses, and soil health initiatives, though adoption depends heavily on affordability, farmer training, and quality assurance. The United Kingdom's disease management priorities are shaped by cereals, horticulture, sustainable farming policy, and regulatory divergence after exiting the European Union, while France shows strong biofungicide relevance in vineyards, fruits, vegetables, cereals, and organic production, supported by residue reduction goals and integrated pest management. Canada's biofungicide use is supported by canola, cereals, pulses, greenhouse vegetables, fruits, and turf applications, with emphasis on disease prevention under short growing seasons and variable humidity. Italy and Spain both combine high-value horticulture, vineyards, orchards, protected vegetables, and export-sensitive residue requirements, making biological fungicides important for integrated disease control in Mediterranean conditions. Australia faces disease challenges in cereals, grapes, horticulture, and broadacre rotations under highly variable climate conditions, making biofungicides relevant where they improve resilience and resistance management. South Korea's greenhouse vegetables, fruits, rice, and high food safety standards create a favorable setting for biological fungicides integrated with technology-enabled crop monitoring. Brazil has strong relevance due to intensive soybean, corn, sugarcane, coffee, citrus, and horticultural production, where biological inputs are increasingly used alongside conventional practices under high disease pressure. Mexico's export-oriented fruit and vegetable production encourages residue-compatible fungicide programs, particularly in protected agriculture and high-value crops supplying North American markets. Russia's broad cereal and oilseed systems create potential for biological seed treatments and soilborne disease control, although adoption depends on product access, local validation, and distribution.

Actionable Recommendations for Biofungicide Industry Leaders

Industry leaders should prioritize field-proven efficacy by investing in multi-location trials across crop types, disease pressures, climates, soil conditions, and application windows. Product portfolios should be designed around integrated disease programs rather than standalone claims, with clear guidance on preventive timing, tank-mix compatibility, rotation with chemical fungicides, irrigation interactions, and use in organic and conventional systems. Manufacturers should strengthen formulation technologies that improve shelf life, heat tolerance, ultraviolet protection, spore viability, adhesion, dispersibility, and ease of use for foliar, seed, soil, and post-harvest applications. Quality assurance must be treated as a core differentiator, particularly for living microbial products where strain identity, viable counts, contamination control, and storage integrity directly affect performance. Commercial teams should build grower confidence through agronomist-led training, demonstration plots, digital disease alerts, and crop-specific protocols that translate biological science into practical decision-making. Regulatory teams should prepare robust dossiers that clearly document mode of action, environmental safety, residue profile, non-target organism impact, and manufacturing consistency. Partnerships with distributors, cooperatives, greenhouse operators, seed suppliers, universities, and extension networks can accelerate trust and local validation. Leaders should also adopt AI-enabled analytics for strain discovery, fermentation control, disease forecasting, and post-application performance tracking. Finally, sustainability communication should remain evidence-based, avoiding broad claims and instead focusing on measurable benefits such as residue management, resistance management, soil health compatibility, and reduced reliance on repeated single-site fungicide applications.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified, publicly available, and industry-relevant sources. The methodology includes review of agricultural regulatory guidance, biological crop protection registration frameworks, integrated pest management publications, scientific literature on microbial and biochemical fungicides, agronomic extension materials, organic agriculture standards, pesticide residue policies, crop disease management guidance, and sustainability-focused agricultural policy documents. Insights are triangulated across crop categories, disease types, regions, and application methods to ensure that conclusions reflect practical field realities rather than isolated technical claims. Particular emphasis is placed on evidence related to mode of action, product use conditions, disease prevention timing, formulation stability, resistance management, safety profile, and regional adoption drivers. The analysis avoids unsupported numerical projections and excludes market sizing, market share, and forecasting. Regional, group, and country insights are interpreted through verified factors such as crop patterns, regulatory direction, climate-linked disease pressure, organic and residue requirements, protected cultivation trends, food security priorities, and the maturity of integrated pest management systems.

Conclusion

Biofungicides are becoming an essential component of modern crop protection as agriculture responds to fungal disease pressure, resistance concerns, residue restrictions, environmental expectations, and the need for resilient food production systems. Their strongest value emerges when they are used preventively within integrated pest management programs that combine biological, chemical, cultural, and digital tools. The sector is advancing through improved microbial strain selection, formulation science, fermentation control, regulatory recognition, and AI-enabled disease forecasting. Regional adoption patterns vary, but the underlying direction is consistent: growers, regulators, and food supply chains are seeking disease management tools that align efficacy with sustainability and food safety. The next phase of progress will depend on consistent product performance, transparent quality standards, localized agronomic support, and clear communication of where biofungicides work best. Industry leaders that combine scientific rigor, practical field guidance, and data-driven deployment will be best positioned to strengthen the role of biofungicides in sustainable agriculture and integrated fungal disease management.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Biofungicides Market, by Crop Type

• 7.1. Introduction
• 7.2. Cereals & Grains
  • 7.2.1. Maize
  • 7.2.2. Rice
  • 7.2.3. Wheat
• 7.3. Fruits & Vegetables
  • 7.3.1. Grapes
  • 7.3.2. Strawberries
  • 7.3.3. Tomato
• 7.4. Turf & Ornamentals
  • 7.4.1. Flowers
  • 7.4.2. Lawns

8. Biofungicides Market, by Type

• 8.1. Introduction
• 8.2. Biochemical
  • 8.2.1. Allelochemicals
  • 8.2.2. Plant Extracts
• 8.3. Microbial
  • 8.3.1. Bacteria
  • 8.3.2. Fungi

9. Biofungicides Market, by Formulation

• 9.1. Introduction
• 9.2. Emulsifiable Concentrate
• 9.3. Granular
• 9.4. Liquid
• 9.5. Powder

10. Biofungicides Market, by End User

• 10.1. Introduction
• 10.2. Commercial Farming
• 10.3. Greenhouse
• 10.4. Home Gardening
  • 10.4.1. Rural Gardening
  • 10.4.2. Urban Gardening

11. Biofungicides Market, by Application Mode

• 11.1. Introduction
• 11.2. Foliar Spray
  • 11.2.1. Aerial Sprayer
  • 11.2.2. Manual Sprayer
• 11.3. Seed Treatment
  • 11.3.1. Coating
  • 11.3.2. Pelleting
• 11.4. Soil Treatment
  • 11.4.1. Drenching
  • 11.4.2. Fumigation

12. Biofungicides Market, by Region

• 12.1. Asia-Pacific
• 12.2. Europe
• 12.3. North America
• 12.4. Latin America
• 12.5. Africa
• 12.6. Middle East

13. Biofungicides Market, by Group

• 13.1. NATO
• 13.2. G7
• 13.3. European Union
• 13.4. BRICS
• 13.5. ASEAN
• 13.6. GCC

14. Biofungicides Market, by Country

• 14.1. United States
• 14.2. China
• 14.3. Germany
• 14.4. Japan
• 14.5. India
• 14.6. United Kingdom
• 14.7. France
• 14.8. Canada
• 14.9. Italy
• 14.10. Australia
• 14.11. South Korea
• 14.12. Brazil
• 14.13. Mexico
• 14.14. Russia
• 14.15. Spain

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Agrauxine by Lesaffre
• 16.2. Andermatt Biocontrol AG
• 16.3. BASF SE
• 16.4. Bayer AG
• 16.5. Biobest Group NV
• 16.6. Bioceres Crop Solutions Corp.
• 16.7. BioWorks, Inc.
• 16.8. Certis Biologicals LLC
• 16.9. Corteva, Inc.
• 16.10. FMC Corporation
• 16.11. Gowan Company, LLC
• 16.12. IPL Biologicals Limited
• 16.13. Isagro S.p.A.
• 16.14. Koppert B.V.
• 16.15. Lallemand Inc.
• 16.16. LESAFFRE ET COMPAGNIE
• 16.17. Marrone Bio Innovations, Inc.
• 16.18. Mitsui Chemicals Agro, Inc.
• 16.19. Novonesis
• 16.20. Nufarm Limited
• 16.21. Seipasa S.A.
• 16.22. STK Bio-Ag Technologies
• 16.23. Syngenta AG
• 16.24. T. Stanes & Company Limited
• 16.25. UPL Limited